Skip to main content

Lineage Cell Therapeutics, Inc 10-K for FY2025

Lineage Cell Therapeutics, Inc. (LCTX)

10-K 2026-03-05 For: 2025-12-31
View Original
Added on April 12, 2026

About this 10-K

Lineage Cell Therapeutics, Inc filed this 10-K on March 5, 2026, covering the fiscal year ended December 31, 2025 (FY2025).

Headline figures

Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$14.56M
up 53.2% from $9.5M a year earlier
Net loss
$63.53M
compared with a net loss of $18.61M a year earlier
Diluted EPS
-$0.28
compared with -$0.09 a year earlier